Live Breaking News & Updates on Director Daniel Bradbury
Stay updated with breaking news from Director daniel bradbury. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Guggenheim Initiates Coverage on Castle Biosciences (NASDAQ:CSTL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 6,875 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $20.09, for a total transaction of $138,118.75. Following the completion of the sale, the director now directly owns 50,605 […] ....
Stock analysts at Guggenheim began coverage on shares of Castle Biosciences (NASDAQ:CSTL – Get Free Report) in a note issued to investors on Thursday, Briefing.com reports. The brokerage set a “buy” rating and a $25.00 price target on the stock. Guggenheim’s target price would suggest a potential upside of 21.65% from the company’s previous close. […] ....
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,545 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $20.05, for a total value of $191,377.25. Following the transaction, the director now owns 54,502 shares of the company’s stock, valued at […] ....
Portolan Capital Management LLC lifted its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 68.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 431,474 shares of the company’s stock after acquiring an additional 174,825 shares during the […] ....